Stereotactic body radiotherapy (SBRT) is considered the treatment of choice for early-stage non-small-cell lung cancer (NSCLC) if patients are inoperable because of additional medical conditions. This is based on several prospective phase II trials, which reported consistently high rates of local tumor control...
US Plastic Surgeons Commonly Use Fat Grafting Techniques For Breast Reconstruction
7/04/2013
Seventy percent of U.S. plastic surgeons have used fat grafting techniques for breast operations, but they are more likely to use it for breast reconstruction rather than cosmetic breast surgery, reports a survey study in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS)...
Breast Cancer Drug Responsiveness Predicted In Human Tumors
7/04/2013
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body. UNC scientists used GEMMs to develop biomarkers for challenging molecular subtypes of human breast cancer, those for which there are fewer targets and therapies...
Simple Test Could Use Sound Waves For Diagnosing Blood-Related Diseases
7/04/2013
New research reveals that when red blood cells are hit with laser light, they produce high frequency sound waves that contain a great deal of information...
Study Confirms Adding Chemotherapy To Surgery Improves Survival In Advanced Gastric Cancer
7/03/2013
For patients with advanced gastric cancer, treatment with chemotherapy after surgery can reduce the risk of cancer related death by 34% over five years compared to surgery alone, researchers said at the 15th ESMO World Congress in Gastrointestinal Cancer...
Long-Term Night Shift Working Linked to Breast Cancer
7/03/2013
Researchers have found that women who work night shifts for more than 30 years may be at a higher risk of breast cancer than other women. The study, published in the British Medical Journal (BMJ), was done by researchers in Canada. They analyzed the careers of 1,134 women with breast cancer and 1,179 women without the disease...
Researchers Testing Novel Melanoma Vaccine In Clinical Trial
7/03/2013
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well...
Second Draft NICE Guidance For Aggressive Non-Hodgkin Lymphoma Treatment, PIXUVRI® (Pixantrone)
7/03/2013
Cell Therapeutics, Inc...
Activartis' Cancer Immunotherapy Receives Orphan Drug Designation From FDA
7/03/2013
The US FDA have notified the Austrian biotech company Activartis that Orphan Drug Designation (ODD) has been granted for its innovative Cancer Immunotherapy AV0113. The ODD applies specifically to the use of AV0113 for the treatment of malignant glioma, a very aggressive type of brain cancer. The European drug agency EMA already granted ODD at the end of last year...
New Breast Cancer Test Will Help More Women Avoid Unnecessary Chemotherapy
7/03/2013
A new genetic test for one of the most common forms of breast cancer will help doctors better identify those women who should be considered for chemotherapy, and those who can avoid it, say researchers...